scispace - formally typeset
S

Siyang Zheng

Researcher at Pennsylvania State University

Publications -  138
Citations -  5670

Siyang Zheng is an academic researcher from Pennsylvania State University. The author has contributed to research in topics: Circulating tumor cell & Cancer. The author has an hindex of 35, co-authored 127 publications receiving 4745 citations. Previous affiliations of Siyang Zheng include Penn State Cancer Institute & California Institute of Technology.

Papers
More filters
Journal ArticleDOI

Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells

TL;DR: Development of a parylene membrane microfilter device for single stage capture and electrolysis of circulating tumor cells (CTCs) in human blood, and the potential of this device to allow genomic analysis is presented.
Journal ArticleDOI

Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells

TL;DR: A novel parylene membrane filter-based portable microdevice for size-based isolation with high recovery rate and direct on-chip characterization of captured CTC from human peripheral blood has the potential to enable routine CTC analysis in the clinical setting for the effective management of cancer patients.
Journal ArticleDOI

3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood

TL;DR: The paper presents and validates this new 3D microfiltration concept for circulation tumor cell enrichment application and provides a highly valuable tool for assessing and characterizing viable enriched circulating tumor cells in both research and clinical settings.
Journal ArticleDOI

Self-Assembly of Extracellular Vesicle-like Metal–Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins

TL;DR: In vitro and in vivo study manifests that the EV-like nanoparticles can not only protect proteins against protease digestion and evade the immune system clearance but also selectively target homotypic tumor sites and promote tumor cell uptake and autonomous release of the guest protein after internalization.
Journal ArticleDOI

A combinatory strategy for detection of live CTCs using microfiltration and a new telomerase-selective adenovirus

TL;DR: In this article, a new class of recombinant adenovirus containing regulatory elements that repress the telomerase gene (hTERT) gene in normal cells was reported, which showed better selectivity for replication in cancer cells than in normal ones.